•
Stedical Scientific, a Hangzhou-based tissue engineering and regenerative medicine company, has raised over RMB100 million (USD13.7 million) in a Series B financing round co-led by Lapam Capital and Shanghai Healthcare Capital. The funds will support the commercial expansion of its core products, particularly in the US and China, as well…